Open AccessUse of Σ-aminocaproic acid and magnesium in psoriasis therapy
Author(s) -
A. P. Suvorov
Publication year - 1989
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj101269
Subject(s) - psoriasis , protease , proteolysis , disease , medicine , nucleic acid metabolism , mechanism (biology) , pharmacology , intensive care medicine , enzyme , immunology , bioinformatics , biochemistry , chemistry , biology , rna , philosophy , epistemology , gene
Due to the insufficient effectiveness of the existing therapy for psoriasis, the development of new promising ways to treat this widespread chronic relapsing disease is one of the most urgent tasks of practical dermatology. High protease activity, especially in the acute phase of the disease, leads to the disturbance of metabolic regulatory systems, changes protein and nucleic acid metabolism and serves as a trigger mechanism, provoking the manifestation of psoriasis. It becomes obvious that during the progression of dermatosis, proteolysis enzyme inhibitors and medications that help restore the activity of protease inhibitors in the patient's body are justified.